Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$601M |
| 2 |
AGN
Allergan plc
AGN
|
+$478M |
| 3 |
SPDR S&P Aerospace & Defense ETF
XAR
|
+$353M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$300M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$264M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$983M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$672M |
| 3 |
Apple
AAPL
|
+$459M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$392M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$355M |
Sector Composition
| 1 | Technology | 15.81% |
| 2 | Healthcare | 11.73% |
| 3 | Financials | 9.49% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Communication Services | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Kimball Electronics
KE
$759M
| $183K | ﹤0.01% |
12,506
-3,823
| -23% | -$55.9K |
|
|
ORTX
3002
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $183K | ﹤0.01% |
1,543
+926
| +150% | +$110K |
|
|
TBIO
3003
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $183K | ﹤0.01% |
18,513
-425
| -2% | -$4.2K |
|
|
UXIN
3004
Uxin Ltd
UXIN
$728M
| $181K | ﹤0.01% |
740
| – | – |
|
3005
Old Second Bancorp
OSBC
$943M
| $180K | ﹤0.01% |
14,733
-4,566
| -24% | -$55.8K |
|
3006
Corbus Pharmaceuticals
CRBP
$142M
| $179K | ﹤0.01% |
1,224
-1,176
| -49% | -$172K |
|
3007
Titan Machinery
TITN
$445M
| $178K | ﹤0.01% |
12,439
-3,464
| -22% | -$49.6K |
|
3008
Titan International
TWI
$547M
| $178K | ﹤0.01% |
65,706
-6,770
| -9% | -$18.3K |
|
3009
Willdan Group
WLDN
$1.5B
| $178K | ﹤0.01% |
5,052
-1,356
| -21% | -$47.8K |
|
|
IOTS
3010
DELISTED
Adesto Technologies Corporation Common Stock
IOTS
| $178K | ﹤0.01% |
20,750
+3,502
| +20% | +$30K |
|
3011
Ribbon Communications
RBBN
$682M
| $177K | ﹤0.01% |
30,276
-9,431
| -24% | -$55.1K |
|
|
HPR
3012
DELISTED
HighPoint Resources Corporation
HPR
| $177K | ﹤0.01% |
2,212
-382
| -15% | -$30.6K |
|
3013
Franklin Covey
FC
$244M
| $176K | ﹤0.01% |
5,045
-1,236
| -20% | -$43.1K |
|
3014
Investar Holding Corp
ISTR
$221M
| $176K | ﹤0.01% |
7,400
+1,371
| +23% | +$32.6K |
|
3015
Sterling Infrastructure
STRL
$9.76B
| $176K | ﹤0.01% |
13,345
-12,677
| -49% | -$167K |
|
3016
First Bancorp
FNLC
$300M
| $175K | ﹤0.01% |
6,400
-418
| -6% | -$11.4K |
|
3017
Geron
GERN
$810M
| $175K | ﹤0.01% |
131,555
+16,358
| +14% | +$21.8K |
|
3018
Nathan's Famous
NATH
$439M
| $175K | ﹤0.01% |
2,439
-421
| -15% | -$30.2K |
|
|
GMLP
3019
DELISTED
Golar LNG Partners LP
GMLP
| $175K | ﹤0.01% |
18,321
+1,447
| +9% | +$13.8K |
|
|
CBIO
3020
Crescent Biopharma, Inc. Common Stock
CBIO
$178M
| $174K | ﹤0.01% |
403
+60
| +17% | +$25.9K |
|
3021
Protagonist Therapeutics
PTGX
$3.68B
| $174K | ﹤0.01% |
14,498
-10,477
| -42% | -$126K |
|
3022
RiverFront Strategic Income Fund
RIGS
$93M
| $174K | ﹤0.01% |
7,000
| – | – |
|
3023
West Bancorporation
WTBA
$347M
| $174K | ﹤0.01% |
8,026
-2,423
| -23% | -$52.5K |
|
3024
Citizens
CIA
$271M
| $173K | ﹤0.01% |
25,135
-7,779
| -24% | -$53.5K |
|
|
BDSI
3025
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $173K | ﹤0.01% |
41,254
-16,896
| -29% | -$70.9K |
|